Yokohama, Japan

Hiroshi Takagi

This inventor holds 51 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents, primarily in L-Cysteine Production (CPC class 4271). Top assignees: Canon Kabushiki Kaisha, Ajinomoto Co., Ltd., Nara Institute of Science and Technology. Active years: 1984-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Takagi. Retrieved from https://idiyas.com/inventor/hiroshi-takagi-fev92gp6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 74.5


 

Average Co-Inventor Count = 3.5

ph-index = 13

Forward Citations = 656(Granted Patents)

Forward Citations (Not Self Cited) = 639(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Kawasaki, JP (1984 - 1990)
  • Hiroshima-ken, JP (2004)
  • Yokohama, JP (1986 - 2005)
  • Fukui, JP (2005 - 2012)
  • Kanagawa, JP (1995 - 2016)
  • Nara, JP (2016)
  • Ikoma, JP (2012 - 2017)

Company Filing History:


Years Active: 1984-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
L-Cysteine
Mutant Acetyltransferase
Image Forming Apparatus
Physiologically Active Peptides
Electron Beam Apparatus
Magnetic Recording Medium
Thin Film Forming Device
Liquid Jet Head
Recombinant DNA
Indwelling Needle
Power Distribution Control
Puncturing Device
51 patents (USPTO):Explore Patents

Title: Hiroshi Takagi: A Pioneering Inventor in Yokohama

Introduction:

Hiroshi Takagi, a renowned inventor hailing from Yokohama, Japan, has made significant contributions in the field of biotechnology. With an impressive portfolio of 51 patents, Takagi's latest innovations include Enterobacteriaceae bacteria exhibiting increased L-cysteine producing ability and yeast with enhanced resistance to freezing stress. Let's delve deeper into Takagi's groundbreaking work and notable collaborations.

Latest Patents:

Takagi's recent patents highlight his expertise in biotechnological advancements. In the first patent, he presents a method to produce L-cysteine inexpensively and efficiently by modifying a bacterium from the Enterobacteriaceae family. The modified bacterium demonstrates an increased capacity to produce L-cysteine in the presence of sulfate, achieved by deleting the C-terminal region of its thiosulfate-binding protein.

In another pioneering patent, Takagi focuses on yeast strains with heightened resistance to freezing stress. By inactivating the POG1 gene, he develops yeast that can better survive freezing conditions. This breakthrough has substantial implications, particularly in the food production industry.

Career Highlights:

Throughout his career, Hiroshi Takagi has made notable contributions to several esteemed companies. He held positions at Canon Kabushiki Kaisha, a global leader in imaging and optical products, and Ajinomoto Co., Ltd., a prominent Japanese food and biotechnology company. His collaborations with these companies have allowed him to bring his innovations to scale and impact industries on a larger scale.

Collaborations:

Takagi's collaborations with fellow inventors have played a crucial role in advancing his research and harnessing new insights. Two of his notable coworkers include Kenji Suzuki and Shigeru Nakamori. Together, they have combined their expertise and shared their knowledge to propel forward biotechnological innovations, particularly in the areas of L-cysteine production and freezing stress resistance.

Conclusion:

Hiroshi Takagi's contributions to the field of biotechnology, with his diverse range of patents and groundbreaking innovations, have undoubtedly established him as a pioneering inventor. Through his novel approaches in modifying bacteria and yeast strains, Takagi offers cost-effective and sustainable solutions for producing L-cysteine and enhancing freezing stress resilience. His collaborations and career journey further demonstrate his dedication to advancing scientific progress. As the world continues to seek innovative solutions, Hiroshi Takagi's work remains invaluable in shaping the future of biotechnology and related industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…